tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Yee, 119 are a BUY (74.38%), 41 are a HOLD (25.63%).
Analyst Michael Yee, currently employed at UBS, carries an average stock price target met ratio of 57.54% that have a potential upside of 38.43% achieved within 209 days. Previously, Michael Yee worked at JEFFERIES.
Michael Yee’s has documented 645 price targets and ratings displayed on 41 stocks. The coverage is on Healthcare, Industrials, Pharmaceuticals sectors.
Most recent stock forecast was given on MRNA, Moderna at 12-Dec-2025.
Analyst best performing recommendations are on IMRX (IMMUNEERING CORP).
The best stock recommendation documented was for KOD (KODIAK SCIENCES) at 7/24/2023. The price target of $3 was fulfilled within 3 days with a profit of $0.95 (24.05%) receiving and performance score of 80.17.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$200
$198.8 (16566.67%)
$3960
4 years 6 months 22 days ago
(17-Jun-2021)
0/4 (0%)
$103 (106.19%)
Buy
$100
$98.8 (8233.33%)
$3600
4 years 11 months 26 days ago
(13-Jan-2021)
2/4 (50%)
$-22.4 (-18.30%)
139
Hold
$120
$118.8 (9900.00%)
$2280
5 years 8 months 2 days ago
(06-May-2020)
5/5 (100%)
$16.79 (16.27%)
44
Hold
$120
$118.8 (9900.00%)
$3000
5 years 8 months 2 days ago
(06-May-2020)
6/6 (100%)
$16.79 (16.27%)
45
Sell
$120
$118.8 (9900.00%)
$1200
6 years 2 months 18 days ago
(21-Oct-2019)
7/7 (100%)
$-165.6 (-57.98%)
161
Which stock is Michael Yee is most bullish on?
Which stock is Michael Yee is most reserved on?
What Year was the first public recommendation made by Michael Yee?
